Coronary flow reserve measurements in hypertension

Medical Clinics of North America

Volumn 88, Issue 1, 2004, Pages 99-113

  Kelm, Malte ^a   Strauer, Bodo E ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ALGORITHM; ANGIOGRAPHY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; CORONARY BLOOD VESSEL; CORONARY SINUS; CORONARY VASCULAR RESISTANCE; DIAGNOSTIC VALUE; DILUTION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; GUIDE WIRE; HEART CATHETERIZATION; HEMODYNAMICS; HEMOPERFUSION; HUMAN; HYPERTENSION; MICROANGIOPATHY; MICROCIRCULATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; SCINTIANGIOGRAPHY; ST SEGMENT DEPRESSION; STATISTICAL SIGNIFICANCE; STRESS ECHOCARDIOGRAPHY; THERMODILUTION;

EID: 0742304962     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(03)00119-6     Document Type: Review

References (65)

1. Guidelines Subcommittee. 1999 World health organization-international society of hypertension guidelines for the management of hypertension. J Hypertens. 17:1999;151-183.
2. Cuspidi C., Ambrosioni E., Mancia G., Pessina A.C., Trimarco B., Zanchetti A., et al. Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the assessment of prognostic risk observational survey. J Hypertens. 20:2002;1307-1314.
3. Slama M., Susic D., Varagic J., Frohlich E.D. Diastolic dysfunction in hypertension. Curr Opin Cardiol. 17:2002;368-373.
4. Schillaci G., Pasqualini L., Verdecchia P., Vaudo G., Marchesi S., Porcellati C., et al. Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. J Am Coll Cardiol. 39:2002;2005-2011.
5. Strauer B.E. The significance of coronary reserve in clinical heart disease. J Am Coll Cardiol. 15:1990;775-783.
6. Anversa P., Ricci R., Olivetti G. Quantitative structural analysis of the myocardium during physiologic growth and induced cardiac hypertrophy. J Am Coll Cardiol. 7:1986;1140-1149.
7. Muller J.M., Davis M.J., Chilian W.M. Integrated regulation of pressure and flow in the coronary microcirculation. Cardiovasc Res. 32:1996;668-678.
8. Feigl E.O. Coronary physiology. Physiol Rev. 63:1983;1-84.
9. Marcus M.L., Chilian W.M., Kanatsuka H., Dellsperger K.C., Eastham C.L., Lamping K.G. Understanding the coronary circulation through studies at the microvascular level. Circulation. 82:1990;1-7.
10. Uren N.G., Crake T. Resistive vessel function in coronary artery disease. Heart. 76:1996;299-304.
11. Strauer B.E. The coronary circulation in hypertensive heart disease. Hypertension. 6:(suppl III):1984;III-74-III-80.
12. Quyyumi A.A., Dakak N., Andrews N.P., Gilligan D.M., Panza J.A., Cannon R.O. III. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation. 92:1995;320-326.
13. Motz W., Vogt M., Rabenau O., Scheler S., Lückhoff A., Strauer B.E. Evidence of endothelial dysfunction in coronary resistance vessels in patients with angina pectoris and normal coronary angiograms. Am J Cardiol. 68:1991;996-1003.
14. Treasure C.B., Klein J.L., Vita J.A., Manoukian S.V., Renwick G.H., Selwyn A.P., et al. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation. 87:1993;86-93.
15. Antony I., Nitenberg A., Foult J.M., Aptecar E. Coronary vasodilator reserve in untreated and treated hypertensive patients with and without left ventricular hypertrophy. J Am Coll Cardiol. 22:1993;514-520.
16. Brush J.E., Cannon R.O. III, Schenke W.H., Bonow R.O., Leon M.L., Maron B.J., et al. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med. 319:1988;1302-1307.
17. Kelm M., Schäfer S., Mingers S., Heydthausen M., Vogt M., Motz W., et al. Left ventricular mass is linked to cardiac noradrenaline in normotensive and hypertensive patients. J Hypertens. 14:1996;1357-1364.
18. Folkow B., Grimby G., Thulesius O. Adaptive structural changes of the vascular walls in hypertension and their relation to the control of the peripheral resistance. Acta Physiol Scand. 44:1958;255-272.
19. Baumbach G.L., Heistad D.D. Remodeling of cerebral arterioles in chronic hypertension. Hypertension. 13:1989;968-972.
20. Schiffrin E.L., Hayoz D. How to access vascular remodelling in small and medium-sized muscular arteries in humans. J Hypertens. 15:1997;571-584.
21. James J.N. Morphologic characteristics and functional significance of focal fibromuscular dysplasia of small coronary arteries. Am J Cardiol. 65:1990;12G-22G.
22. Schwartzkopff B., Motz W., Frenzel H., Vogt M., Knauer S., Strauer B.E. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation. 88:1993;993-1003.
23. Harrison D.G., Florentine M.S., Brooks L.A., Cooper S.M., Marcus M.L. The effect of hypertension and left ventricular hypertrophy on the lower range of coronary autoregulation. Circulation. 77:1988;1108-1115.
24. Polese A., Cesare de N., Montorsi P., Fabbiocchi F., Guazzi M., Loaldi A., et al. Upward shift of the lower range of coronary flow autoregulation in hypertensive patients with hypertrophy of the left ventricle. Circulation. 83:1991;845-853.
25. Motz W., Strauer B.E. Improvement of coronary flow reserve after long-term therapy with enalapril. Hypertension. 27:1996;1031-1038.
26. Scheler S., Motz W., Strauer B.E. Mechanism of angina pectoris in patients with systemic hypertension and normal epicardial coronary arteries by arteriogram. Am J Cardiol. 73:1994;478-482.
27. Houghton J., Frank M.J., Carr A.A., Dohlen T.W., Prisant L.M. Relations among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive artery disease. J Am Coll Cardiol. 15:1990;43-51.
28. Iriarte M., Caso R., Murga N., Faus J.M., Sagastagoitia D., Molinero E., et al. Microvascular angina pectoris in hypertensive patients with left ventricular hypertrophy and diagnostic value of exercise thallium-201 scintigraphy. Am J Cardiol. 5:1995;335-339.
29. Fragasso G., Lu C., Dabroski P., Pagnotta P., Sheiban I., Chierchia S.L. Comparison of stress/rest myocardial perfusion tomography, dipyridamole and dobutamine stress echocardiography for the detection of coronary disease in hypertensive patients with chest pain and positive exercise test. J Am Coll Cardiol. 34:1999;441-447.
30. Picano E., Palinkas A., Amyot R. Diagnosis of myocardial ischemia in hypertensive patients. J Hypertens. 19:2001;1177-1183.
31. Leischik R., Rore J., Caspari G., Skyschally A., Hensch G., Erbel R. Contrast echocardiography for assessment of myocardial perfusion. Herz. 22:1997;40-50.
32. Iliceto S., Marangelli V., Memmola C., Rizzon P. Transesophageal Doppler echocardiography evaluation of coronary blood flow velocity in baseline conditions and during dipyridamole-induced coronary vasodilation. Circulation. 83:1991;61-69.
33. Kozakova M., Palombo C., Pratali D., Pittella G., Galetta F., Abbatet L. Mechanisms of coronary flow reserve impairment in human hypertension: an integrated approach by transthoracic and transesophageal echocardiography. Hypertension. 29:1997;551-559.
34. De Silva R., Camici P.G. Role of positron emission tomography in the investigation of human coronary circulatory. Cardiovasc Res. 28:1994;1595-1612.
35. Nitenberg A., Antony I. Coronary vascular reserve in humans: a critical review of methods of evaluation and of interpretation of the results. Eur Heart J. 16:(suppl I):1995;7-21.
36. Camici P.G., Gropler R.J., Jones T., Abbate A., Maseri A., Melin J.A., et al. The impact of myocardial blood with nbPET on the understanding of cardiac diseases. Eur Heart J. 17:1996;25-34.
37. Parodi O., Neglia D., Sambuceti G., Marabotti C., Palombo C., Donato L. Regional myocardial blood flow and coronary reserve in hypertensive patients: the effect of the therapy. Drugs. 44:(suppl 1):1992;48-55.
38. Matheijnen N.A.A., Louwerenberg H.W., Van Rugge F.P., Arens R.P.G.H., Kauer B., De Roos A., et al. Comparison of ultrafast dipyridamole magnetic resonance imaging with dipyridamole Sesta MIBI SPECT for deletion of perfusion abnormalities in patients with one-vessel coronary artery disease, assessment by quantitative model fitting. Magn Reson Med. 35:1996;221-228.
39. Foltz W.D., Huang H., Fort S., Wright G.A. Vasodilator response assessment in porcine myocardium with magnetic resonance relaxometry. Circulation. 106:2002;2714-2719.
40. Ibrahim T., Nekolla S.G., Schreiber K., Odaka K., Volz S., Mehilli J., et al. Assessment of coronary flow reserve: comparison between contrast-enhanced magnetic resonance imaging and positron emission tomography. J Am Coll Cardiol. 39:2002;864-870.
41. Ganz W., Tamura K., Marcus H.S., Donoso R., Yoshida S., Swan H.J.C. Measurement of coronary sinus blood flow by continuous thermodilution in man. Circulation. 44:1971;181-195.
42. Gensini G.G., Di Giorgi S., Coskun O., Palacio A., Kelly A.E. Anatomy of the coronary circulation in living man: coronary venography. Circulation. 31:1965;778-784.
43. Bagger J.P. Coronary sinus blood flow determination by the thermodilution technique: influence of catheter position and respiration. Cardiovasc Res. 19:1984;27-31.
44. Rossen J.D., Oskarsson H., Stenberg R.G., Braun P., Talman C.L., Winniford M.D. Simultaneous measurement of coronary flow reserve by left anterior descending coronary artery Doppler and great cardiac vein thermodilution methods. J Am Coll Cardiol. 20:1992;402-407.
45. Lefroy D.C., Crake T., Uren N.G., Davies G.J., Maseri A. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans. Circulation. 88:1993;43-54.
46. Kelm M., Rath J., Pölitz B., Strauer B.E. Relevanz und Methoden zur Bestimmung der koronaren Flussreserve. Z Kardiol. 87:(suppl 2):1998;1-5.
47. Strauer B.E. Das hochdruckherz. 3rd edition:1991;Springer Verlag, Berlin.
48. Tauchert M., Kochsiek K., Heiss H.W., Rau G., Bretschneider H.J. Technik der Organdurchblutungsmessung mit der Argon- Methode. Z Kreislaufforsch. 60:1971;871-880.
49. Ritman E.L. Angiographic measurement of coronary blood flow reserve. Does it work? Circulation. 82:1990;1533-1535.
50. Eigler N.L., Pfaff J.M., Zeiher A., Whitinge J.S., Forrester J.S. Digital angiographic impulse response analysis of regional myocardial perfusion: linearity, reproducibility, accuracy, and comparison with conventional indicator dilution curve parameters in phantom and canine models. Circ Res. 64:1989;853-866.
51. Pijls N.H.J., Uijen G.J.H., Hoevelaken A., Arts T., Aengevaeren W.R.M., Bos H.S., et al. Mean transit time for the assessment of myocardial perfusion by videodensitometry. Circulation. 81:1990;1331-1340.
52. Gibson C.M., Cannon C.P., Daley W.L., Dodge J.T., Alexander B., Marble S.J., et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 93:1996;879-888.
53. Kern M.J. A simplified method to measure coronary blood flow velocity in patients: validation and application of a Judkins-style Doppler-tipped angiographic catheter. Am Heart J. 120:1990;1202-1212.
54. Doucette J.W., Corl P.D., Payne H.M., Flynn A.E., Goto M., Nassi M., et al. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation. 85:1992;1899-1911.
55. Schulman D.S., Lasorda D., Farah T., Soukas P., Reichek N., Joye J.D. Correlations between coronary flow reserve measured with a Doppler guide wire and treadmill exercise testing. Am Heart J. 134:1997;99-104.
56. Meeder J.G., Peel H.O., Blanksma P.K., Tan E.S., Pruim J., van der Wall E.E., et al. Comparison between positron emission tomography myocardial perfusion imaging and intracoronary Doppler flow velocity measurement at rest and during cold pressor testing in angiographically normal coronary arteries in patients with one-vessel coronary artery disease. Am J Cardiol. 78:1996;526-531.
57. 201Tl imaging and coronary angiography. Circulation. 96:1997;484-490.
58. Chou T.M., Sudhir K., Iwanaga S., Chatterjee K., Yock P.G. Measurement of volumetric coronary blood flow by simultaneous intravascular two-dimensional and Doppler ultrasound: validation in an animal model. Am Heart J. 128:1994;237-243.
59. Kern M.J., De Bruyne B., Pijls N.H.J. From research to clinical practice: current role of intracoronary physiologically based decision making in the cardiac catheterization laboratory. J Am Coll Cardiol. 30:1997;613-620.
60. Dell'Omo G., Penno G., Giorgi D., Di Bello V., Mariani M., Pedrinelli R. Association between high-normal albuminuria and risk factors for cardiovascular and renal disease in essential hypertensive men; (original investigations: pathogenesis and treatment of kidney disease and hypertension). Am J Kidney Dis. 40:2002;1-8.
61. Redon J., Williams B. Microalbuminuria in essential hypertension: redefining the threshold. J Hypertens. 20:2002;353-355.
62. Higashi Y., Nakagawa K., Kimura M., Noma K., Hara K., Sasaki S., et al. Circadian variation of blood pressure and endothelial function in patients with essential hypertension: a comparison of dippers and non-dippers. J Am Coll Cardiol. 40:2002;2039-2043.
63. Yuda S., Short L., Leano R., Marwick T.H. Myocardial abnormalities in hypertensive patients with normal and abnormal left ventricular filling: a study of ultrasound tissue characterization and strain. Clin Sci. 103:2002;283-293.
64. Taddei S., Salvetti A. Endothelial dysfunction in essential hypertension: clinical implications. J Hypertens. 20:2002;1671-1674.
65. Strauer B.E., Schwartzkopff B., Kelm M. Assessing the coronary circulation in hypertension. J Hypertens. 16:1998;1221-1233.